Ben Axler, Founder & Chief Investment Officer at Spruce Point Capital Management, explains his concerns on Danimer Scientific including that the growth expansion story is likely to fail. He points out several corporate governance red flags involving past and current CEOs.
Morning Trade Live
22 Apr 2021
SHARE
The Watch List
19 Apr 2022
Trading 360
04 Feb 2022
Trading 360
14 Feb 2022
The Watch List
17 Mar 2022
The Watch List
22 Mar 2022
Morning Trade Live
18 Feb 2022